KOBO BIOTECH LIMITED (KOBO.BO)
INR 2.96
(4.96%)
INR 2.96
(4.96%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.48 Million INR | 95.06% |
| 2022 | -50.17 Million INR | -139.84% |
| 2021 | 125.95 Million INR | 260.59% |
| 2020 | -78.43 Million INR | 7.58% |
| 2019 | -84.85 Million INR | 7.15% |
| 2018 | -91.39 Million INR | 4.07% |
| 2017 | -95.27 Million INR | 11.11% |
| 2016 | -107.18 Million INR | -212.43% |
| 2015 | -34.3 Million INR | 80.63% |
| 2014 | -177.07 Million INR | -6.86% |
| 2013 | -165.7 Million INR | -149.14% |
| 2012 | 337.23 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -654 Thousand INR | 94.79% |
| 2023 Q1 | -12.4 Million INR | 30.8% |
| 2023 Q4 | -12.56 Million INR | -2.03% |
| 2023 Q3 | -12.31 Million INR | -1.28% |
| 2023 Q2 | -12.15 Million INR | 2.04% |
| 2023 FY | -49.43 Million INR | 1.47% |
| 2022 Q1 | -14.82 Million INR | 85.77% |
| 2022 FY | -50.17 Million INR | -139.84% |
| 2022 Q4 | -17.93 Million INR | -50.56% |
| 2022 Q3 | -11.91 Million INR | -8.07% |
| 2022 Q2 | -11.02 Million INR | 25.64% |
| 2021 Q4 | -104.16 Million INR | -672.57% |
| 2021 FY | 125.95 Million INR | 260.59% |
| 2021 Q3 | -13.48 Million INR | 22.01% |
| 2021 Q2 | -17.28 Million INR | -7.1% |
| 2021 Q1 | -16.14 Million INR | -0.58% |
| 2020 Q2 | -20.88 Million INR | -4.05% |
| 2020 Q4 | -16.04 Million INR | 25.11% |
| 2020 FY | -78.43 Million INR | 7.58% |
| 2020 Q1 | -20.07 Million INR | 4.23% |
| 2020 Q3 | -21.42 Million INR | -2.61% |
| 2019 Q4 | -20.95 Million INR | -0.26% |
| 2019 Q2 | -21.47 Million INR | 0.19% |
| 2019 FY | -84.85 Million INR | 7.15% |
| 2019 Q1 | -21.52 Million INR | 6.27% |
| 2019 Q3 | -20.9 Million INR | 2.68% |
| 2018 Q3 | -22.4 Million INR | -1.16% |
| 2018 Q2 | -22.15 Million INR | 7.22% |
| 2018 Q1 | -23.87 Million INR | -0.45% |
| 2018 FY | -91.39 Million INR | 4.07% |
| 2018 Q4 | -22.95 Million INR | -2.46% |
| 2017 Q2 | -25.32 Million INR | -6.8% |
| 2017 Q3 | -22.46 Million INR | 11.29% |
| 2017 Q1 | -23.71 Million INR | 0.79% |
| 2017 FY | -95.27 Million INR | 11.11% |
| 2017 Q4 | -23.76 Million INR | -5.79% |
| 2016 Q1 | -27.82 Million INR | 68.59% |
| 2016 FY | -107.18 Million INR | -212.43% |
| 2016 Q4 | -23.9 Million INR | 10.91% |
| 2016 Q3 | -26.83 Million INR | 6.27% |
| 2016 Q2 | -28.62 Million INR | -2.87% |
| 2015 Q1 | 41.24 Million INR | 186.94% |
| 2015 Q2 | 44.81 Million INR | 8.66% |
| 2015 FY | -34.3 Million INR | 80.63% |
| 2015 Q4 | -88.59 Million INR | -178.8% |
| 2015 Q3 | -31.77 Million INR | -170.9% |
| 2014 Q1 | -44.93 Million INR | 0.0% |
| 2014 FY | -177.07 Million INR | -6.86% |
| 2014 Q3 | -39.75 Million INR | 14.28% |
| 2014 Q4 | -47.44 Million INR | -19.32% |
| 2014 Q2 | -46.37 Million INR | -3.21% |
| 2013 FY | -165.7 Million INR | -149.14% |
| 2012 FY | 337.23 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| ANG Lifesciences India Limited | 12.8 Million INR | 119.367% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 103.197% |
| Bacil Pharma Limited | -1.89 Million INR | -30.916% |
| BDH Industries Limited | 169.01 Million INR | 101.467% |
| Beryl Drugs Limited | 14.73 Million INR | 116.834% |
| Cian Healthcare Limited | 53.96 Million INR | 104.595% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 115.09% |
| Concord Drugs Limited | 24.87 Million INR | 109.971% |
| Deccan Health Care Limited | 185.32 Million INR | 101.338% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 104.615% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | 127.586% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 100.29% |
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | 566.341% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 100.371% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | 131.124% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 100.495% |
| Panchsheel Organics Limited | 288.28 Million INR | 100.86% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 93.432% |
| Parnax Lab Limited | 166.84 Million INR | 101.486% |
| Makers Laboratories Limited | -34.91 Million INR | 92.896% |
| Medi-Caps Limited | -17.21 Million INR | 85.59% |
| MedPlus Health Services Limited | 1.31 Billion INR | 100.188% |
| Phaarmasia Limited | - INR | Infinity% |
| Parmax Pharma Limited | 3.75 Million INR | 166.053% |
| Patidar Buildcon Limited | -1.83 Million INR | -35.076% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 103.847% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -510.837% |
| Trident Lifeline Limited | 72.21 Million INR | 103.434% |
| Tyche Industries Limited | 111.22 Million INR | 102.23% |
| Vivanza Biosciences Limited | 14.83 Million INR | 116.721% |
| PRAVEG LIMITED | 185.06 Million INR | 101.34% |
| Smruthi Organics Limited | - INR | Infinity% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 107.261% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 101.15% |
| Sastasundar Ventures Limited | -229.64 Million INR | 98.92% |
| Transchem Limited | -17.43 Million INR | 85.779% |
| Trinity League India Limited | 1.17 Million INR | 311.424% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 100.731% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 75.559% |
| Sunil Healthcare Limited | -19.98 Million INR | 87.588% |
| Syschem (India) Limited | 504.91 Million INR | 100.491% |
| Zenith Healthcare Limited | 196 Thousand INR | 1365.306% |
| Zenlabs Ethica Limited | 89.27 Million INR | 102.778% |
| Mercury Laboratories Limited | 62.14 Million INR | 103.99% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 102.513% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 104.047% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 98.451% |
| Roopa Industries Limited | 48.05 Million INR | 105.161% |
| PANJON LTD. | - INR | Infinity% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 98.339% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 86.158% |
| Anuh Pharma Limited | 682.19 Million INR | 100.364% |
| Crestchem Limited | 27.25 Million INR | 109.099% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 78.903% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 114.482% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 100.681% |
| Trimurthi Limited | -6.14 Million INR | 59.629% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 101.05% |
| Norris Medicines Limited | 11.15 Million INR | 122.228% |
| Veerhealth Care Limited | 34.19 Million INR | 107.253% |
| Lactose (India) Limited | 137.78 Million INR | 101.8% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 97.993% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 100.568% |
| Gennex Laboratories Limited | 146.61 Million INR | 101.691% |
| Denis Chem Lab Limited | 142.87 Million INR | 101.736% |
| Colinz Laboratories Limited | 14.64 Million INR | 116.936% |
| Godavari Drugs Limited | -67.67 Million INR | 96.335% |
| Zenotech Laboratories Limited | 242.37 Million INR | 101.023% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 100.433% |
| Bharat Parenterals Limited | 733.49 Million INR | 100.338% |
| Coral Laboratories Limited | 142.63 Million INR | 101.739% |
| Evoq Remedies Limited | 42.91 Million INR | 105.779% |
| Kerala Ayurveda Limited | 48.04 Million INR | 105.162% |
| Natural Capsules Limited | 112.4 Million INR | 102.206% |
| Auro Laboratories Limited | 95.77 Million INR | 102.589% |